Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple‐negative breast cancer cohort

Triple‐negative breast cancer (TNBC) accounts for 15–20% of all newly diagnosed breast cancers, and is enriched for germline mutation of BRCA. In Asian patients diagnosed with breast cancer, 268 deleterious mutations of BRCA1 and 242 of BRCA2 have been identified so far, including a reported BRCA1 f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoran, Li, Huiping, Shao, Bin, Wu, Jianmin, Kong, Weiyao, Song, Guohong, Jiang, Hanfang, Wang, Jing, Wan, Fengling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345662/
https://www.ncbi.nlm.nih.gov/pubmed/28135048
http://dx.doi.org/10.1002/cam4.1004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345662/
https://www.ncbi.nlm.nih.gov/pubmed/28135048
http://dx.doi.org/10.1002/cam4.1004

Ejemplares similares